Juno's Chief Science Officer, Dr. Tim Garrett,will be a panelist on GBTA Ready. Safe. Travel. Summit, February 17th. Sign up to hear him discuss the lastest on testing and the variants. linkedin.com/events/ready-sa…

Juno Metabolomics launches a novel COVID-19 test and trace solution with a simple, non-invasive sample collection kit. JunoCOVID-DX is fast, highly accurate, and offers high volume testing: junometabolomics.com/junocov…

Juno Metabolomics is collaborating with Good Pharmaceutical Development Co. (GPDC) in a medical cannabis clinical study. GPDC is recruiting clinics for involvement in the study. If you'd like to participate in this medical cannabis initiative: [email protected]

We are in the media! Metabolomics: The Next Step in Personalized Cannabis Medicine cannabissciencetech.com/arti…

Dr. Tim Garrett, CSO at JUNO Metabolomics has presented JUNO's innovative approach in measuring the efficacy of medical cannabis in the human body at Cannabis Science Conference. More info: junometabolomics.com/cannabi… #MedicalCannabis #metabolomics #disease

JUNO metabolomics at Cannabis Science Conference. We will present our innovation tomorrow (Friday 5th) at 1 pm PST about how we’ll impact on medical cannabis in healthcare. More info: junometabolomics.com/cannabi…

Big Question: How do you know your medical cannabis is working? Introducing JUNO Medical Cannabis Metabolism Analysis and Research Services Dr. Timothy Garrett, CSO presents our next-generation technology at Cannabis Science Conference Portland, OR on Sept 6th. Please join us!